American Century Companies Inc Arcutis Biotherapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 1,464,311 shares of ARQT stock, worth $19.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,464,311

Previous 1,231,700 18.89%

Holding current value

$19.6 Million

Previous $11.5 Million 18.89%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$8.32 - $11.0 $1.94 Million - $2.56 Million	232,611 Added 18.89%	1,464,311 $13.6 Million
Q2 2024 Aug 07, 2024	BUY	$7.24 - $12.53 $1.38 Million - $2.39 Million	190,754 Added 18.33%	1,231,700 $11.5 Million
Q1 2024 May 14, 2024	BUY	$3.25 - $11.77 $419,714 - $1.52 Million	129,143 Added 14.16%	1,040,946 $10.3 Million
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $1.68 Million - $4.39 Million	911,803 New	911,803 $2.95 Million
Q3 2023 Nov 13, 2023	BUY	$5.31 - $10.98 $1,141 - $2,360	215 Added 0.04%	510,094 $2.71 Million
Q2 2023 Aug 14, 2023	BUY	$7.51 - $15.0 $13,968 - $27,900	1,860 Added 0.37%	509,879 $4.86 Million
Q1 2023 May 11, 2023	SELL	$10.23 - $17.14 $745,460 - $1.25 Million	-72,870 Reduced 12.54%	508,019 $5.59 Million
Q4 2022 Feb 13, 2023	SELL	$13.96 - $20.4 $28,576 - $41,758	-2,047 Reduced 0.35%	580,889 $8.6 Million
Q3 2022 Nov 14, 2022	BUY	$17.85 - $26.95 $326,512 - $492,969	18,292 Added 3.24%	582,936 $11.1 Million
Q2 2022 Aug 12, 2022	BUY	$16.33 - $22.2 $654,588 - $889,887	40,085 Added 7.64%	564,644 $12 Million
Q1 2022 May 11, 2022	BUY	$14.38 - $22.79 $539,077 - $854,351	37,488 Added 7.7%	524,559 $10.1 Million
Q4 2021 Feb 07, 2022	BUY	$14.98 - $25.5 $1.66 Million - $2.83 Million	110,997 Added 29.51%	487,071 $10.1 Million
Q3 2021 Nov 10, 2021	SELL	$19.28 - $27.1 $10,526 - $14,796	-546 Reduced 0.14%	376,074 $8.99 Million
Q2 2021 Aug 05, 2021	BUY	$24.42 - $34.75 $20,122 - $28,634	824 Added 0.22%	376,620 $10.3 Million
Q1 2021 May 14, 2021	BUY	$24.47 - $36.98 $2.14 Million - $3.24 Million	87,496 Added 30.35%	375,796 $10.9 Million
Q4 2020 Feb 12, 2021	BUY	$17.82 - $31.73 $5.14 Million - $9.15 Million	288,300 New	288,300 $8.11 Million

Others Institutions Holding ARQT

# of Institutions

197

Shares Held

129M

Call Options Held

738K

Put Options Held

82K

View Full List

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $807M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Arcutis Biotherapeutics, Inc. Transaction History